{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:33:17Z","timestamp":1793082797553,"version":"4.5.0"},"reference-count":253,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejphar.2026.179400","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:08:19Z","timestamp":1791414499000},"page":"179400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Telmisartan: distinct pharmacological features, partial PPAR-\u03b3 modulation, and pleiotropic therapeutic potential"],"prefix":"10.1016","volume":"1037","author":[{"given":"Abhishek","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5311-9051","authenticated-orcid":false,"family":"Badruddeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juber","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Irfan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179400_bib1","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3390\/pharmaceutics15092290","article-title":"Therapeutic implications of renin\u2013angiotensin system modulators in alzheimer's dementia","volume":"15","author":"Ababei","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2026.179400_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117388","article-title":"Telmisartan\/17\u03b2-estradiol mitigated cognitive deficit in an ovariectomized rat model of Alzheimer's disease: Modulation of ACE1\/ACE2 and AT1\/AT2 ratio","volume":"245","author":"Abdelkader","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2026.179400_bib3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s43094-024-00655-9","article-title":"Expanding telmisartan's therapeutic horizon: exploring its multifaceted mechanisms beyond cardiovascular disorders","volume":"10","author":"Ahire","year":"2024","journal-title":"Future J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2026.179400_bib4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3390\/ijms23020616","article-title":"Neuroinflammation: a potential risk for dementia","volume":"23","author":"Ahmad","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179400_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2024.102986","article-title":"Role of angiotensin II in non-alcoholic steatosis development","volume":"55","author":"Alvarado-Ojeda","year":"2024","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/hr.2012.17","article-title":"Structural basis for telmisartan-mediated partial activation of PPAR gamma","volume":"35","author":"Amano","year":"2012","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib7","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/01.RES.0000073585.50092.14","article-title":"Peroxisome proliferator-activated receptor gamma (PPAR\u03b3) expression is decreased in pulmonary hypertension and affects endothelial cell growth","volume":"92","author":"Ameshima","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3923\/ijp.2010.584.590","article-title":"Pharmacotherapeutic approaches of parkinson's disease","volume":"6","author":"Ansari","year":"2010","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3317\/jraas.2002.038","article-title":"Effects of telmisartan on arterial stiffness in type 2 diabetes patients with essential hypertension","volume":"3","author":"Asmar","year":"2002","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"key":"10.1016\/j.ejphar.2026.179400_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pharep.2016.12.004","article-title":"Telmisartan attenuates diabetes induced depression in rats","volume":"69","author":"Aswar","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2026.179400_bib11","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.2147\/DMSO.S265399","article-title":"Anti-diabetic effect of Telmisartan through its partial PPAR\u03b3-Agonistic activity","volume":"13","author":"Ayza","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.ejphar.2026.179400_bib12","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.2147\/DMSO.S265399","article-title":"Anti-diabetic effect of Telmisartan through its partial PPAR\u03b3-Agonistic activity","volume":"13","author":"Ayza","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.ejphar.2026.179400_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1291\/hypres.30.49","article-title":"Effects of telmisartan and losartan on insulin resistance in hypertensive patients with metabolic syndrome","volume":"30","author":"Bahadir","year":"2007","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/0091270006297225","article-title":"Pharmacokinetics of oral doses of telmisartan and nisoldipine, given alone and in combination, in patients with essential hypertension","volume":"47","author":"Bajcetic","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib15","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1111\/j.1476-5381.2012.01938.x","article-title":"Submaximal PPAR\u03b3 activation and endothelial dysfunction: new perspectives for the management of cardiovascular disorders","volume":"166","author":"Balakumar","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2165\/00003495-200666010-00004","article-title":"Telmisartan","volume":"66","author":"Battershill","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2026.179400_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.steroids.2014.04.005","article-title":"Mineralocorticoid receptors in immune cells: emerging role in cardiovascular disease","volume":"91","author":"Bene","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.ejphar.2026.179400_bib18","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/HJH.0b013e3282f76481","article-title":"Pleiotropic effects of telmisartan: still more to come?","volume":"26","author":"Benndorf","year":"2008","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2026.179400_bib19","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of Telmisartan as a unique angiotensin II receptor antagonist with selective PPAR\u03b3\u2013Modulating activity","volume":"43","author":"Benson","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2026.179400_bib20","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3390\/biom12101429","article-title":"Impact of the renin-angiotensin system on the pathogeny and pharmacotherapeutics of neurodegenerative diseases","volume":"12","author":"Bild","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejphar.2026.179400_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.36740\/WLek202002122","article-title":"The effect of therapy with olmesartan or telmisartan in patients with arterial hypertension combined with obesity","volume":"73","author":"Bochar","year":"2020","journal-title":"Wiad. Lek."},{"key":"10.1016\/j.ejphar.2026.179400_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-72449-1","article-title":"Atorvastatin and telmisartan do not reduce nasopharyngeal carriage of SARS-CoV-2 in mild or moderate COVID-19 in a phase IIb randomized controlled trial","volume":"14","author":"Bonnet","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179400_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1742-1241.2007.01441.x","article-title":"Antidiabetic medications in overweight\/obese patients with type 2 diabetes: drawbacks of current drugs and potential advantages of incretin-based treatment on body weight","volume":"61","author":"Bonora","year":"2007","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.ejphar.2026.179400_bib24","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41440-018-0040-6","article-title":"The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review","volume":"41","author":"Bor\u00e9m","year":"2018","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2025.112518","article-title":"The spleen-liver axis supports obesity-induced systemic and fatty liver inflammation via MDSC and NKT cell enrichment","volume":"601","author":"Brummer","year":"2025","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejphar.2026.179400_bib26","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3390\/ijms23031772","article-title":"Immunomodulatory activity of the Most commonly used antihypertensive drugs\u2014angiotensin converting enzyme inhibitors and angiotensin II receptor blockers","volume":"23","author":"Bryniarski","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179400_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.CIR.0000102381.57477.50","article-title":"Endothelial dysfunction in pulmonary hypertension","volume":"109","author":"Budhiraja","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.179400_bib28","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.3390\/cells13232001","article-title":"Pathophysiology of angiotensin II-Mediated hypertension, cardiac hypertrophy, and failure: a perspective from macrophages","volume":"13","author":"Carter","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.179400_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J. Obes. Metab. Syndr."},{"key":"10.1016\/j.ejphar.2026.179400_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4077\/CJP.2018.BAG516","article-title":"Stimulatory action of telmisartan, an antagonist of angiotensin II receptor, on voltage-gated Na^+ current: experimental and theoretical studies","volume":"61","author":"Chang","year":"2018","journal-title":"Chin. J. Physiol."},{"key":"10.1016\/j.ejphar.2026.179400_bib31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/1440-1681.12943","article-title":"Activation of voltage\u2010gated sodium current and inhibition of mediated potassium current caused by telmisartan, an antagonist of angiotensin II type\u20101 receptor, in HL\u20101 atrial cardiomyocytes","volume":"45","author":"Chang","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2026.179400_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12935-023-02963-1","article-title":"Antiproliferative and apoptotic effects of telmisartan in human glioma cells","volume":"23","author":"Chang","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejphar.2026.179400_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1715032","article-title":"Comparative effectiveness of telmisartan vs. other angiotensin receptor blockers in reducing hypertension-related cerebrovascular and cardiovascular events: a real-world retrospective study using the TriNetX network","volume":"12","author":"Chen","year":"2026","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2026.179400_bib34","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2147\/DMSO.S187092","article-title":"Telmisartan is effective to ameliorate metabolic syndrome in rat model \u2013 a preclinical report","volume":"11","author":"Cheng","year":"2018","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.ejphar.2026.179400_bib35","first-page":"47","article-title":"Improvement of treatment in persons with arterial hypertension and type 2 diabetes mellitus","author":"Chernatska","year":"2018","journal-title":"Georgian Med. News"},{"key":"10.1016\/j.ejphar.2026.179400_bib36","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1124\/jpet.117.244798","article-title":"Impaired pulmonary arterial vasoconstriction and nitric oxide\u2013mediated relaxation underlie severe pulmonary hypertension in the sugen-hypoxia rat model","volume":"364","author":"Christou","year":"2018","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2026.179400_bib37","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2337\/db07-0839","article-title":"Liver-specific peroxisome proliferator\u2013activated receptor \u03b1 target gene regulation by the angiotensin type 1 receptor blocker telmisartan","volume":"57","author":"Clemenz","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2026.179400_bib38","doi-asserted-by":"crossref","first-page":"17985","DOI":"10.1073\/pnas.0605545103","article-title":"Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney","volume":"103","author":"Crowley","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2026.179400_bib39","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahl\u00f6f","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2026.179400_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2026.100130","article-title":"International union of basic and clinical pharmacology. CXXI. Apelin receptor pharmacology in the human cardiovascular system and emerging clinical applications","volume":"78","author":"Davenport","year":"2026","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2026.179400_bib41","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1586\/14737175.7.9.1085","article-title":"The PRoFESS trial: future impact on secondary stroke prevention","volume":"7","author":"Diener","year":"2007","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejphar.2026.179400_bib42","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1097\/01.hjh.0000357906.60778.7f","article-title":"Preventing stroke: the PRoFESS, ONTARGET, and TRANSCEND trial programs","volume":"27","author":"Diener","year":"2009","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2026.179400_bib43","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1038\/s41440-024-01909-y","article-title":"Therapeutic opportunities in targeting the protective arm of the renin-angiotensin system to improve insulin sensitivity: a mechanistic review","volume":"47","author":"Dominici","year":"2024","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","article-title":"Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions","volume":"8","author":"Dong-Chen","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2026.179400_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.880298","article-title":"Association of inflammatory cytokines with non-alcoholic fatty liver disease","volume":"13","author":"Duan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2026.179400_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100962","article-title":"Telmisartan for treatment of Covid-19 patients: an open multicenter randomized clinical trial","volume":"37","author":"Duarte","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ejphar.2026.179400_bib47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/ndt\/gfad194","article-title":"Heart disease and stroke statistics 2023 update from the American heart Association\u2014Implications for nephrology","volume":"39","author":"Edwards","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2026.179400_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.21776\/ub.mnj.2020.006.01.9","article-title":"The effects neuroprotection of telmisartan on stroke with hypertension","volume":"6","author":"ErnawatI","year":"2020","journal-title":"MNJ (Malang Neurology Journal)"},{"key":"10.1016\/j.ejphar.2026.179400_bib49","doi-asserted-by":"crossref","first-page":"421","DOI":"10.5152\/tjg.2020.19365","article-title":"Effects of orlistat or Telmisartan on the serum free fatty acids in non-alcoholic fatty liver disease patients: an open-labeled randomized controlled study","volume":"33","author":"Esmail","year":"2022","journal-title":"Turk. J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2026.179400_bib50","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1039\/D4CP03291H","article-title":"Computational insights in repurposing a cardiovascular drug for Alzheimer's disease: the role of aromatic amino acids in stabilizing the drug through \u03c0\u2013\u03c0 stacking interaction","volume":"27","author":"Esther Rubavathy","year":"2025","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ejphar.2026.179400_bib51","series-title":"Pritor (Telmisartan): European Public Assessment Report (EPAR)","year":"2009"},{"key":"10.1016\/j.ejphar.2026.179400_bib52","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/acps.12799","article-title":"The effect of adjunctive telmisartan treatment on psychopathology and cognition in patients with schizophrenia","volume":"136","author":"Fan","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ejphar.2026.179400_bib53","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/acps.12799","article-title":"The effect of adjunctive telmisartan treatment on psychopathology and cognition in patients with schizophrenia","volume":"136","author":"Fan","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ejphar.2026.179400_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.970292","article-title":"The AMPK pathway in fatty liver disease","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejphar.2026.179400_bib55","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.179400_bib56","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/j.1523-1755.2005.00675.x","article-title":"Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors","volume":"68","author":"Ferrario","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2026.179400_bib57","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/en.2010-1312","article-title":"Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization in high-fat-fed mice","volume":"152","author":"Fujisaka","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2026.179400_bib58","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/hr.2015.2","article-title":"Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension","volume":"38","author":"Furuhashi","year":"2015","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib59","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s13318-024-00895-3","article-title":"Uridine 5\u2032-Diphospho-glucuronosyltransferase 1A3 (UGT1A3) prediction of hepatic clearance of organic anion transporting polypeptide 1B3 (OATP1B3) substrate Telmisartan by glucuronidation using in Vitro\u2013In vivo extrapolation (IVIVE)","volume":"49","author":"Gabor-Worwa","year":"2024","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2026.179400_bib60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/picr.PICR_93_17","article-title":"Effect of telmisartan on blood pressure in patients of type 2 diabetes with or without complications","volume":"9","author":"Gadge","year":"2018","journal-title":"Perspect. Clin. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cellsig.2018.06.007","article-title":"Angiotensin (1\u20137) does not interact directly with MAS1, but can potently antagonize signaling from the AT1 receptor","volume":"50","author":"Gaidarov","year":"2018","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2026.179400_bib62","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of Endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179400_bib63","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-025-04903-4","article-title":"Pharmacokinetic comparison of ezetimibe\/rosuvastatin\/telmisartan 10\/20\/80 mg fixed-dose combination versus coadministration of separate tablets in healthy participants","author":"Goh","year":"2026","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.ejphar.2026.179400_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/5569410","article-title":"ACE2 and Apelin-13: biomarkers with a prognostic value in congestive heart failure","volume":"2021","author":"Goidescu","year":"2021","journal-title":"Dis. Markers"},{"key":"10.1016\/j.ejphar.2026.179400_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/5569410","article-title":"ACE2 and Apelin-13: biomarkers with a prognostic value in congestive heart failure","volume":"2021","author":"Goidescu","year":"2021","journal-title":"Dis. Markers"},{"key":"10.1016\/j.ejphar.2026.179400_bib66","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/hr.2013.121","article-title":"Effect of telmisartan vs. ramipril on \u2018dipping\u2019 status and blood pressure variability: pooled analysis of the PRISMA studies","volume":"37","author":"Gosse","year":"2014","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib67","doi-asserted-by":"crossref","DOI":"10.23736\/S2724-5683.23.06463-3","article-title":"Standard of care plus telmisartan on respiratory failure due to COVID-19 (STAR-COVID trial)","volume":"72","author":"Gracia-Ramos","year":"2024","journal-title":"Minerva Cardiol. Angiol."},{"key":"10.1016\/j.ejphar.2026.179400_bib68","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mce.2016.10.021","article-title":"Differential effects of angiotensin receptor blockers on pancreatic islet remodelling and glucose homeostasis in diet-induced obese mice","volume":"439","author":"Graus-Nunes","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejphar.2026.179400_bib69","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/2045-8932.78101","article-title":"Is peroxisome proliferator\u2010activated receptor gamma (PPAR\u03b3) a therapeutic target for the treatment of pulmonary hypertension?","volume":"1","author":"Green","year":"2011","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.ejphar.2026.179400_bib70","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12975-022-01121-5","article-title":"A novel hybrid of telmisartan and borneol ameliorates neuroinflammation and white matter injury in ischemic stroke through ATF3\/CH25H axis","volume":"15","author":"Guan","year":"2024","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib71","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1089\/neu.2021.0062","article-title":"Epidemiology of chronic effects of traumatic brain injury","volume":"38","author":"Haarbauer-Krupa","year":"2021","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ejphar.2026.179400_bib72","first-page":"249","article-title":"Effect of telmisartan in experimentally induced diabetetes mellitus in rats","volume":"1","author":"Hamed","year":"2007","journal-title":"Int. J. Health Sci."},{"key":"10.1016\/j.ejphar.2026.179400_bib73","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.brainres.2010.07.017","article-title":"Telmisartan, a partial agonist of peroxisome proliferator-activated receptor \u03b3, improves impairment of spatial memory and hippocampal apoptosis in rats treated with repeated cerebral ischemia","volume":"1353","author":"Haraguchi","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib74","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2165\/00003495-199550020-00003","article-title":"Gender effects in pharmacokinetics and pharmacodynamics","volume":"50","author":"Harris","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2026.179400_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3694","article-title":"Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-\u03b2","volume":"9","author":"Hart","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2026.179400_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153010","article-title":"Therapeutic potential of renin angiotensin system inhibitors in cancer cells metastasis","volume":"216","author":"Hashemzehi","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ejphar.2026.179400_bib77","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/cpt.1928","article-title":"UGT1A3 and sex are major determinants of telmisartan pharmacokinetics\u2014A comprehensive pharmacogenomic study","volume":"108","author":"Hirvensalo","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2026.179400_bib78","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/0002-9149(76)90357-X","article-title":"Role of hypertension in atherosclerosis and cardiovascular disease","volume":"38","author":"Hollander","year":"1976","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179400_bib79","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5853\/jos.2017.00164","article-title":"Blood pressure management for stroke prevention and in acute stroke","volume":"19","author":"Hong","year":"2017","journal-title":"J. Stroke"},{"key":"10.1016\/j.ejphar.2026.179400_bib80","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41582-023-00884-1","article-title":"Molecular biomarkers for vascular cognitive impairment and dementia","volume":"19","author":"Hosoki","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejphar.2026.179400_bib81","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00228-016-2130-1","article-title":"Telmisartan increases systemic exposure to rosuvastatin after single and multiple doses, and in vitro studies show telmisartan inhibits ABCG2-mediated transport of rosuvastatin","volume":"72","author":"Hu","year":"2016","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib84","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3390\/biophysica4040032","article-title":"Modulatory impact of tefluthrin, Telmisartan, and KB-R7943 on voltage-gated Na+ currents","volume":"4","author":"Huang","year":"2024","journal-title":"Biophysica"},{"key":"10.1016\/j.ejphar.2026.179400_bib82","article-title":"Inhibitory effects of telmisartan on culture and proliferation of and Kv1.3 potassium channel expression in peripheral blood CD4 + T lymphocytes from Xinjiang Kazakh patients with hypertension","volume":"17","author":"Huang","year":"2016","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"key":"10.1016\/j.ejphar.2026.179400_bib83","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2174\/1570159X18666200620230321","article-title":"Crosstalk between inflammation and the BBB in stroke","volume":"18","author":"Huang","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib85","volume":"35","author":"Hwang","year":"2020","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.ejphar.2026.179400_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116169","article-title":"Effects of telmisartan on metabolic syndrome components: a comprehensive review","volume":"171","author":"Imenshahidi","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.179400_bib87","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2710.2010.01161.x","article-title":"Inhibition of intestinal cholesterol absorption might explain cholesterol-lowering effect of telmisartan","volume":"36","author":"Inoue","year":"2011","journal-title":"J. Clin. Pharm. Therapeut."},{"key":"10.1016\/j.ejphar.2026.179400_bib88","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1124\/dmd.105.009175","article-title":"Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans","volume":"34","author":"Ishiguro","year":"2006","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.ejphar.2026.179400_bib89","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0149-2918(02)85026-3","article-title":"Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis","volume":"24","author":"Iskedjian","year":"2002","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejphar.2026.179400_bib90","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1291\/hypres.31.161","article-title":"Attenuation of focal brain ischemia by telmisartan, an angiotensin II type 1 receptor blocker, in atherosclerotic apolipoprotein E-Deficient mice","volume":"31","author":"Iwai","year":"2008","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib91","doi-asserted-by":"crossref","first-page":"474","DOI":"10.37349\/edd.2024.00062","article-title":"Mitochondrial ROS, a trigger for mitochondrial dysfunction and inflammasome activation and a therapeutic target in liver diseases","volume":"3","author":"Jaara","year":"2024","journal-title":"Explor. Digest. Dis."},{"key":"10.1016\/j.ejphar.2026.179400_bib92","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0140-6736(91)91042-S","article-title":"Chronic renal failure: pathophysiology","volume":"338","author":"Jacobson","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2026.179400_bib93","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-072175","article-title":"Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial","author":"Jardine","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2026.179400_bib94","first-page":"3035","article-title":"Effect of telmisartan on blood pressure and lipid profile in hypertensive patients with dyslipidemia","volume":"4","author":"Jayapriya","year":"2013","journal-title":"Int. J. Pharm. Life Sci."},{"key":"10.1016\/j.ejphar.2026.179400_bib95","doi-asserted-by":"crossref","first-page":"8656","DOI":"10.1007\/s12035-024-04127-2","article-title":"Gene expression analysis in T2DM and its associated microvascular diabetic complications: focus on risk factor and RAAS pathway","volume":"61","author":"Jena","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2026.179400_bib96","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1124\/jpet.107.120097","article-title":"Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral hemorrhage","volume":"322","author":"Jung","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2026.179400_bib97","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1124\/jpet.113.211722","article-title":"Distinct properties of telmisartan on agonistic activities for peroxisome proliferator-activated receptor \u03b3 among clinically used angiotensin II receptor blockers: drug-target interaction analyses","volume":"349","author":"Kakuta","year":"2014","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2026.179400_bib98","doi-asserted-by":"crossref","DOI":"10.1080\/19932820.2025.2585617","article-title":"Telmisartan targets Nrf2-HO1 axis in MASLD modulating oxidative stress, inflammation, and mitochondrial dysfunction: mechanistic insights","volume":"20","author":"Kamar","year":"2025","journal-title":"Libyan J. Med."},{"key":"10.1016\/j.ejphar.2026.179400_bib99","doi-asserted-by":"crossref","DOI":"10.1080\/19932820.2025.2585617","article-title":"Telmisartan targets Nrf2-HO1 axis in MASLD modulating oxidative stress, inflammation, and mitochondrial dysfunction: mechanistic insights","volume":"20","author":"Kamar","year":"2025","journal-title":"Libyan J. Med."},{"key":"10.1016\/j.ejphar.2026.179400_bib100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-55-1-33","article-title":"Factors of risk in the development of coronary heart Disease\u2014six-year Follow-up experience","volume":"55","author":"Kannel","year":"1961","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2026.179400_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104969","article-title":"Inflammasomes as biomarkers and therapeutic targets in traumatic brain injury and related-neurodegenerative diseases: a comprehensive overview","volume":"144","author":"Kattan","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2026.179400_bib102","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1186\/s12889-025-24898-0","article-title":"Changing patterns in health-seeking behaviour and prescription practices for treatment of hypertension in nine districts \u2013 insights from India hypertension control initiative, 2018-19 and 2023-24","volume":"25","author":"Kaur","year":"2025","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ejphar.2026.179400_bib103","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12640-019-00085-z","article-title":"Telmisartan protects against aluminum-induced alzheimer-like pathological changes in rats","volume":"37","author":"Khalifa","year":"2020","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib105","first-page":"649","article-title":"Alzheimer disease: a review","volume":"5","author":"Khan","year":"2016","journal-title":"World J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2026.179400_bib104","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.2174\/1871527313666141023160448","article-title":"Current challenges to overcome in the management of type 2 diabetes mellitus and associated neurological disorders","volume":"13","author":"Khan","year":"2014","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.ejphar.2026.179400_bib106","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/psp4.12671","article-title":"Application of a dual mechanistic approach to support bilastine dose selection for older adults","volume":"10","author":"Kim","year":"2021","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib107","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/17474930231210448","article-title":"Global stroke statistics 2023: availability of reperfusion services around the world","volume":"19","author":"Kim","year":"2024","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.ejphar.2026.179400_bib108","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/met.2018.0129","article-title":"Even short-term Telmisartan treatment ameliorated insulin resistance but had no influence on serum adiponectin and tumor necrosis factor-alpha levels in hypertensive patients with metabolic syndrome","volume":"17","author":"Kiyici","year":"2019","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"10.1016\/j.ejphar.2026.179400_bib109","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cyto.2013.02.001","article-title":"Impact of telmisartan on the inflammatory state in patients with coronary atherosclerosis \u2013 influence on IP-10, TNF-\u03b1 and MCP-1","volume":"62","author":"Klinghammer","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.ejphar.2026.179400_bib110","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1097\/HJH.0b013e328357fa98","article-title":"Sympathoinhibitory effects of telmisartan through the reduction of oxidative stress in the rostral ventrolateral medulla of obesity-induced hypertensive rats","volume":"30","author":"Konno","year":"2012","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2026.179400_bib111","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1042\/CS20170131","article-title":"AT1-receptor blockade attenuates outward aortic remodeling associated with diet-induced obesity in mice","volume":"131","author":"Krueger","year":"2017","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejphar.2026.179400_bib112","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000334951","article-title":"Telmisartan improves cardiometabolic profile in Obese patients with arterial hypertension","volume":"35","author":"Kubik","year":"2012","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib113","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/CAD.0000000000001509","article-title":"Exploring the repurposing potential of telmisartan drug in breast cancer: an in-silico and in-vitro approach","volume":"34","author":"Kumar","year":"2023","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.ejphar.2026.179400_bib114","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.4103\/jfmpc.jfmpc_787_22","article-title":"Blood pressure-lowering effect of telmisartan compared to losartan among mild to moderate essential hypertensive adult subjects: a meta-analysis","volume":"11","author":"Kumari","year":"2022","journal-title":"J. Fam. Med. Prim. Care"},{"key":"10.1016\/j.ejphar.2026.179400_bib115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12975-013-0321-y","article-title":"Long-term effect of telmisartan on alzheimer's amyloid genesis in SHR-SR after tMCAO","volume":"6","author":"Kurata","year":"2015","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib116","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1007\/s12035-020-02253-1","article-title":"Telmisartan inhibits the NLRP3 inflammasome by activating the PI3K pathway in neural stem cells injured by oxygen-glucose deprivation","volume":"58","author":"Kwon","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2026.179400_bib117","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00126097-200408000-00005","article-title":"Sustained antihypertensive activity of telmisartan compared with valsartan","volume":"9","author":"Lacourci\u00e8re","year":"2004","journal-title":"Blood Pres. Monit."},{"key":"10.1016\/j.ejphar.2026.179400_bib118","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41531-024-00650-0","article-title":"Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission","volume":"10","author":"Lage","year":"2024","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.ejphar.2026.179400_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00902","article-title":"Telmisartan, an antagonist of angiotensin II receptors, accentuates voltage-gated Na+ currents and hippocampal neuronal excitability","volume":"14","author":"Lai","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179400_bib120","article-title":"Effects of high-intensity statin combined with telmisartan versus amlodipine on glucose metabolism in hypertensive atherosclerotic cardiovascular disease patients with impaired fasting glucose: a randomized multicenter trial","volume":"101","author":"Lee","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.ejphar.2026.179400_bib125","article-title":"TGR5 deficiency in excitatory neurons ameliorates Alzheimer's pathology by regulating APP processing","volume":"10","author":"Li","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejphar.2026.179400_bib122","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12888-018-1880-y","article-title":"Effects of stress on behavior and resting-state fMRI in rats and evaluation of telmisartan therapy in a stress-induced depression model","volume":"18","author":"Li","year":"2018","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179400_bib124","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1016\/j.apsb.2021.03.018","article-title":"Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease","volume":"11","author":"Li","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2026.179400_bib121","article-title":"Telmisartan activates PPAR\u03b4 to improve symptoms of unpredictable chronic mild stress-induced depression in mice","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179400_bib126","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.2147\/DDDT.S524048","article-title":"Decoding drug interactions: character and degree of pharmacokinetic interactions between Telmisartan and sorafenib or donafenib in rats","volume":"19","author":"Li","year":"2025","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejphar.2026.179400_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105255","article-title":"PPAR\u03b3 activation-mediated Egr-1 inhibition benefits against brain injury in an experimental ischaemic stroke model","volume":"29","author":"Li","year":"2020","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.ejphar.2026.179400_bib127","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/alz.12680","article-title":"Hypertension, a dementia polygenic risk score, APOE genotype, and incident dementia","volume":"19","author":"Littlejohns","year":"2023","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejphar.2026.179400_bib128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003707","article-title":"Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: a population-based cohort study","volume":"18","author":"Liu","year":"2021","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejphar.2026.179400_bib129","doi-asserted-by":"crossref","DOI":"10.1002\/VIW.20240023","article-title":"Back cover: photoacoustic imaging in brain disorders: current progress and clinical applications (view 4\/2024)","volume":"5","author":"Liu","year":"2024","journal-title":"View"},{"key":"10.1016\/j.ejphar.2026.179400_bib130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/YCO.0000000000000843","article-title":"Recent research advances in young-onset dementia","volume":"36","author":"Loi","year":"2023","journal-title":"Curr. Opin. Psychiatr."},{"key":"10.1016\/j.ejphar.2026.179400_bib131","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41598-025-30304-x","article-title":"Telmisartan reduces systemic inflammation and alters the renin-angiotensin system in mild COVID-19","volume":"16","author":"Lu","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179400_bib132","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914494","article-title":"PPAR\u03b3 in atherosclerotic endothelial dysfunction: regulatory compounds and PTMs","volume":"24","author":"Luan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179400_bib133","first-page":"8990","article-title":"Protective effects of pentoxifylline on acute liver injury induced by thioacetamide in rats","volume":"8","author":"Luo","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ejphar.2026.179400_bib134","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/labinvest.2011.45","article-title":"Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma","volume":"91","author":"Maejima","year":"2011","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ejphar.2026.179400_bib135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.26442\/SG29177","article-title":"Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application","volume":"14","author":"Maksimov","year":"2017","journal-title":"Syst. Hypertens."},{"key":"10.1016\/j.ejphar.2026.179400_bib136","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1194\/jlr.M077891","article-title":"Loss of fatty acid binding protein-1 alters the hepatic endocannabinoid system response to a high-fat diet","volume":"58","author":"Martin","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib137","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.3390\/ijms20133197","article-title":"Telmisartan inhibits cell proliferation and tumor growth of esophageal squamous cell carcinoma by inducing S-Phase arrest in vitro and in vivo","volume":"20","author":"Matsui","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179400_bib138","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/s41440-022-00922-3","article-title":"Impact of renin\u2013angiotensin\u2013aldosterone system inhibitors on COVID-19","volume":"45","author":"Matsuzawa","year":"2022","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib139","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2147\/VHRM.S9447","article-title":"Telmisartan and cardioprotection","author":"McFarlane","year":"2011","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.ejphar.2026.179400_bib140","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.22301","article-title":"Comparative study of the effects of azilsartan and telmisartan on insulin resistance and metabolic biomarkers in essential hypertension associated with type 2 diabetes mellitus","author":"Meher","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.ejphar.2026.179400_bib141","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.22301","article-title":"Comparative study of the effects of azilsartan and telmisartan on insulin resistance and metabolic biomarkers in essential hypertension associated with type 2 diabetes mellitus","author":"Meher","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.ejphar.2026.179400_bib142","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1124\/pr.112.007278","article-title":"A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists","volume":"65","author":"Michel","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2026.179400_bib143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/652738","article-title":"Modulation of immunity and inflammation by the mineralocorticoid receptor and aldosterone","author":"Mu\u00f1oz-Durango","year":"2015","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.ejphar.2026.179400_bib144","doi-asserted-by":"crossref","DOI":"10.1177\/1559325820982190","article-title":"Telmisartan self-nanoemulsifying drug delivery system, compared with standard telmisartan, more effectively improves hepatic fibrosis in rats","volume":"18","author":"Murad","year":"2020","journal-title":"Dose Response"},{"key":"10.1016\/j.ejphar.2026.179400_bib145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214727","article-title":"Effects of azilsartan compared with telmisartan on insulin resistance in patients with essential hypertension and type 2 diabetes mellitus: an open-label, randomized clinical trial","volume":"14","author":"Naruse","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179400_bib149","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/JOE-13-0227","article-title":"The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis","volume":"219","author":"O'Carroll","year":"2013","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ejphar.2026.179400_bib146","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s40263-019-00632-4","article-title":"The possible role of the angiotensin system in the pathophysiology of schizophrenia: implications for pharmacotherapy","volume":"33","author":"Oh","year":"2019","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179400_bib190","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ahj.2004.03.020","volume":"148","year":"2004","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2026.179400_bib147","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/hrt.2010.214031","article-title":"Controversies in the cardiovascular management of type 2 diabetes","volume":"97","author":"Opie","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.ejphar.2026.179400_bib148","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/01.HYP.37.2.322","article-title":"Reduced hypoxic pulmonary vascular remodeling by nitric oxide from the endothelium","volume":"37","author":"Ozaki","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2026.179400_bib151","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-79096-2","article-title":"Chronically infused angiotensin II induces depressive-like behavior via microglia activation","volume":"10","author":"Park","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179400_bib150","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1038\/s41598-019-40322-1","article-title":"Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by telmisartan","volume":"9","author":"Park","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179400_bib152","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/jamaneurol.2023.3664","article-title":"A new framework for dementia nomenclature","volume":"80","author":"Petersen","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejphar.2026.179400_bib153","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1161\/CIRCULATIONAHA.121.053350","article-title":"Cardiac late sodium channel current is a molecular target for the sodium\/glucose cotransporter 2 inhibitor empagliflozin","volume":"143","author":"Philippaert","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.179400_bib154","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s12264-019-00388-3","article-title":"Dual functions of microglia in ischemic stroke","volume":"35","author":"Qin","year":"2019","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.ejphar.2026.179400_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112707","article-title":"Anti-tumor effects of telmisartan in glioma-astrocyte non-contact co-cultures: a critical role of astrocytic IL-6-mediated paracrine growth promotion","volume":"139","author":"Quan","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib156","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s43440-025-00737-2","article-title":"The application of telmisartan in central nervous system disorders","volume":"77","author":"Quan","year":"2025","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2026.179400_bib157","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/metabo14030153","article-title":"Interleukins: pathogenesis in non-alcoholic fatty liver disease","volume":"14","author":"Rafaqat","year":"2024","journal-title":"Metabolites"},{"key":"10.1016\/j.ejphar.2026.179400_bib158","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.jhh.1001494","article-title":"Comparison of trough effect of telmisartan vs perindopril using self blood pressure measurement: EVERESTE study","volume":"16","author":"Ragot","year":"2002","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.ejphar.2026.179400_bib159","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/ijmr.ijmr_3096_21","article-title":"The Indian registry on current patient profiles & treatment trends in hypertension (RECORD): one year interim analysis","volume":"158","author":"Rajadhyaksha","year":"2023","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib160","article-title":"Traumatic brain injury: mechanisms, manifestations, and visual sequelae","volume":"17","author":"Rauchman","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179400_bib161","article-title":"Effects of telmisartan, an AT1 receptor antagonist, on mitochondria-specific genes expression in a mouse MPTP model of parkinsonism","volume":"26","author":"Ray","year":"2021","journal-title":"Front. Biosci.-Landm."},{"key":"10.1016\/j.ejphar.2026.179400_bib163","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/0003319713512556","article-title":"Combining rosuvastatin with angiotensin-receptor blockers of different PPAR\u03b3-Activating capacity","volume":"66","author":"Rizos","year":"2015","journal-title":"Angiology"},{"key":"10.1016\/j.ejphar.2026.179400_bib164","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11906-014-0463-7","article-title":"The role of adiponectin in endothelial dysfunction and hypertension","volume":"16","author":"Rojas","year":"2014","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.ejphar.2026.179400_bib165","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ddr.21679","article-title":"Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19","volume":"81","author":"Rothlin","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib166","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ad64e0","article-title":"Telmisartan loaded lipid nanocarrier as a potential repurposing approach to treat glioma: characterization, apoptosis evaluation in U87MG cells, pharmacokinetic and molecular simulation study","volume":"35","author":"Rout","year":"2024","journal-title":"Nanotechnology"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179400_bib162","first-page":"461461","article-title":"Stability indicating simultaneous validation of Telmisartan and cilnidipine with forced degradation behavior study by RP-UPLC in tablet dosage form","volume":"2013","author":"Rupareliya","year":"2013","journal-title":"Int. Sch. Res. Notices"},{"key":"10.1016\/j.ejphar.2026.179400_bib167","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1111\/bcp.15411","article-title":"Angiotensin II receptor blockers (ARBs) and manufacturing contamination: a retrospective national register study into suspected associated adverse drug reactions","volume":"88","author":"Salim","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib168","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/Angiotensin-(1\u20137)\/MAS axis of the renin-angiotensin system: focus on Angiotensin-(1\u20137)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2026.179400_bib169","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2026.179400_bib170","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1161\/ATVBAHA.108.167403","article-title":"Are the mechanisms for NO-Dependent vascular remodeling different from vasorelaxation in vivo?","volume":"28","author":"Schleicher","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2026.179400_bib171","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.2337\/diabetes.54.12.3442","article-title":"Molecular characterization of new selective peroxisome proliferator\u2013activated receptor \u03b3 modulators with angiotensin receptor blocking activity","volume":"54","author":"Schupp","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2026.179400_bib172","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12640-025-00759-x","article-title":"Retraction note: telmisartan ameliorates astroglial and dopaminergic functions in a mouse model of chronic parkinsonism","volume":"43","author":"Sekar","year":"2025","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib173","doi-asserted-by":"crossref","first-page":"F82","DOI":"10.1152\/ajprenal.00139.2006","article-title":"Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II","volume":"292","author":"Shaltout","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2026.179400_bib174","doi-asserted-by":"crossref","DOI":"10.1002\/jcph.70180","article-title":"Physiologically based pharmacokinetic modeling to predict the pharmacokinetics of Sacubitril\/Valsartan in the elderly with renal or hepatic impairment population","volume":"66","author":"Shao","year":"2026","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib175","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7570\/jomes23054","article-title":"Mitochondrial quality control: its role in metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"32","author":"Shin","year":"2023","journal-title":"J. Obes. Metab. Syndr."},{"key":"10.1016\/j.ejphar.2026.179400_bib176","article-title":"Metformin: a review of its therapeutic efficacy and adverse effects","volume":"17","author":"Shurrab","year":"2020","journal-title":"Obes. Med."},{"key":"10.1016\/j.ejphar.2026.179400_bib177","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1476-5381.2012.02192.x","article-title":"The apelin receptor inhibits the angiotensin <scp>II<\/scp> type 1 receptor via allosteric trans\u2010inhibition","volume":"168","author":"Siddiquee","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib179","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1055\/a-2238-1384","article-title":"Targeting abnormal tau phosphorylation for alzheimer's therapeutics","volume":"56","author":"Singh","year":"2024","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib178","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.neo.2020.08.002","article-title":"Targeting AGTR1\/NF-\u03baB\/CXCR4 axis by miR-155 attenuates oncogenesis in glioblastoma","volume":"22","author":"Singh","year":"2020","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejphar.2026.179400_bib180","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1177\/009127000004001202","article-title":"Absorption, metabolism, and excretion of intravenously and orally administered [14C]telmisartan in healthy volunteers","volume":"40","author":"Stangier","year":"2000","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib181","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/147323000002800401","article-title":"Pharmacokinetics of orally and intravenously administered Telmisartan in healthy young and elderly volunteers and in hypertensive patients","volume":"28","author":"Stangier","year":"2000","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib182","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/147323000002800401","article-title":"Pharmacokinetics of orally and intravenously administered Telmisartan in healthy young and elderly volunteers and in hypertensive patients","volume":"28","author":"Stangier","year":"2000","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib183","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1177\/009127000004001208","article-title":"Pharmacokinetics of single-dose telmisartan 120 mg given during and between hemodialysis in subjects with severe renal insufficiency: comparison with healthy volunteers","volume":"40","author":"Stangier","year":"2000","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib184","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/ajh\/hpu076","article-title":"Telmisartan exerts sustained blood pressure control and reduces blood pressure variability in metabolic syndrome by inhibiting sympathetic activity","volume":"27","author":"Sueta","year":"2014","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2026.179400_bib185","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2710.2011.01295.x","article-title":"Systematic review of the effect of telmisartan on insulin sensitivity in hypertensive patients with insulin resistance or diabetes","volume":"37","author":"Suksomboon","year":"2012","journal-title":"J. Clin. Pharm. Therapeut."},{"key":"10.1016\/j.ejphar.2026.179400_bib186","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.7150\/ijbs.7.1077","article-title":"Cardioprotective effects of Telmisartan against heart failure in rats induced by experimental Autoimmune myocarditis through the modulation of angiotensin-converting Enzyme-2\/Angiotensin 1-7\/mas receptor axis","volume":"7","author":"Sukumaran","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2026.179400_bib187","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/hr.2012.196","article-title":"Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials","volume":"36","author":"Takagi","year":"2013","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib188","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.atherosclerosis.2005.08.009","article-title":"Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice","volume":"186","author":"Takaya","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2026.179400_bib189","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/17474124.2021.1914587","article-title":"Liver-spleen axis in nonalcoholic fatty liver disease","volume":"15","author":"Tarantino","year":"2021","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2026.179400_bib191","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1475-2840-12-30","article-title":"AT1-receptor-deficiency induced atheroprotection in diabetic mice is partially mediated via PPAR\u03b3","volume":"12","author":"Tiyerili","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2026.179400_bib192","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbi.2017.04.001","article-title":"Intranasal telmisartan ameliorates brain pathology in five familial Alzheimer's disease mice","volume":"64","author":"Torika","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejphar.2026.179400_bib193","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.bbrc.2011.06.012","article-title":"Telmisartan protects against diabetic vascular complications in a mouse model of obesity and type 2 diabetes, partially through peroxisome proliferator activated receptor-\u03b3-dependent activity","volume":"410","author":"Toyama","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2026.179400_bib194","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.3390\/ijms22157976","article-title":"Cardioprotection by SGLT2 inhibitors\u2014does it all come Down to Na+?","volume":"22","author":"Trum","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179400_bib195","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/psp4.13154","article-title":"Elucidating nonlinear pharmacokinetics of telmisartan: integration of target\u2010mediated drug disposition and OATP1B3\u2010mediated hepatic uptake in a physiologically based model","volume":"13","author":"Tsuchitani","year":"2024","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib196","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/psp4.13154","article-title":"Elucidating nonlinear pharmacokinetics of telmisartan: integration of target\u2010mediated drug disposition and OATP1B3\u2010mediated hepatic uptake in a physiologically based model","volume":"13","author":"Tsuchitani","year":"2024","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib197","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/HYPERTENSIONAHA.109.136879","article-title":"Cognitive deficit in Amyloid-\u03b2\u2013Injected mice was improved by pretreatment with a low dose of Telmisartan partly because of peroxisome proliferator-activated Receptor-\u03b3 activation","volume":"54","author":"Tsukuda","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2026.179400_bib198","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.3390\/ijms24076518","article-title":"Inflammatory processes in alzheimer's disease\u2014pathomechanism, diagnosis and treatment: a review","volume":"24","author":"Twarowski","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179400_bib199","series-title":"Micardis (Telmisartan) Briefing Document for the Cardiovascular and Renal Drugs Advisory Committee","year":"2009"},{"key":"10.1016\/j.ejphar.2026.179400_bib200","series-title":"Micardis (Telmisartan) Full Prescribing Information","year":"2009"},{"key":"10.1016\/j.ejphar.2026.179400_bib201","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1111\/bph.15782","article-title":"The role of the mineralocorticoid receptor in immune cells in cardiovascular disease","volume":"179","author":"van der Heijden","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib202","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/cpt.2744","article-title":"Studying Telmisartan Plasma Exposure, Kidney Distribution, Receptor Occupancy, and Response in Patients With Type 2 Diabetes Using [ <scp> 11 C <\/scp> ]Telmisartan","volume":"112","author":"van der Hoek","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2026.179400_bib203","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00228-009-0678-8","article-title":"Pharmacokinetics and dosage adjustment in patients with renal dysfunction","volume":"65","author":"Verbeeck","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib204","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1093\/brain\/awv172","article-title":"Neurorestoration after traumatic brain injury through angiotensin II receptor blockage","volume":"138","author":"Villapol","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2026.179400_bib205","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/j.ajpath.2015.06.016","article-title":"Hepatic expression of serum amyloid A1 is induced by traumatic brain injury and modulated by telmisartan","volume":"185","author":"Villapol","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2026.179400_bib206","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neubiorev.2021.11.036","article-title":"Blood-based biomarkers of inflammation in mild traumatic brain injury: a systematic review","volume":"132","author":"Visser","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2026.179400_bib207","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2840-4-6","article-title":"Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome","volume":"4","author":"Vitale","year":"2005","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2026.179400_bib208","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/hr.2010.107","article-title":"Improvement of endothelial function in patients with hypertension and type 2 diabetes after treatment with telmisartan","volume":"33","author":"Wago","year":"2010","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib209","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/ijms19010137","article-title":"The sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents renal and liver disease in Western diet induced obesity mice","volume":"19","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179400_bib213","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2026.2644681","article-title":"Gut microbiota metabolic reprogramming drives the development of metabolic diseases in the host","volume":"18","author":"Wang","year":"2026","journal-title":"Gut Microbes"},{"key":"10.1016\/j.ejphar.2026.179400_bib211","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/ajco.13574","article-title":"Telmisartan attenuates human glioblastoma cells proliferation and oncogenicity by inducing the lipid oxidation","volume":"18","author":"Wang","year":"2022","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2026.179400_bib212","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/ajco.13574","article-title":"Telmisartan attenuates human glioblastoma cells proliferation and oncogenicity by inducing the lipid oxidation","volume":"18","author":"Wang","year":"2022","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2026.179400_bib210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113674","article-title":"Telmisartan ameliorates A\u03b2 oligomer-induced inflammation via PPAR\u03b3\/PTEN pathway in BV2 microglial cells","volume":"171","author":"Wang","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib214","doi-asserted-by":"crossref","first-page":"36A","DOI":"10.1016\/j.amjcard.2009.10.008","article-title":"Telmisartan in high-risk cardiovascular patients","volume":"105","author":"Weber","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179400_bib215","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s11596-016-1628-1","article-title":"Telmisartan reduced cerebral edema by inhibiting NLRP3 inflammasome in mice with cold brain injury","volume":"36","author":"Wei","year":"2016","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"10.1016\/j.ejphar.2026.179400_bib216","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ahj.2005.02.014","article-title":"Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting","volume":"151","author":"White","year":"2006","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2026.179400_bib217","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ahj.2005.02.014","article-title":"Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting","volume":"151","author":"White","year":"2006","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2026.179400_bib219","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1527-3466.2000.tb00039.x","article-title":"A review on telmisartan: a novel, long\u2010acting angiotensin II\u2010Receptor antagonist","volume":"18","author":"Wienen","year":"2000","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.ejphar.2026.179400_bib218","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1476-5381.1993.tb13800.x","article-title":"Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277","volume":"110","author":"Wienen","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib220","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.hjh.0000194364.11516.ab","article-title":"The prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I)","volume":"24","author":"Williams","year":"2006","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2026.179400_bib221","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.pharep.2013.11.002","article-title":"Telmisartan attenuates cognitive impairment caused by chronic stress in rats","volume":"66","author":"Wincewicz","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2026.179400_bib222","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/1470320314526269","article-title":"Angiotensin II AT1 receptor blockade by telmisartan reduces impairment of spatial maze performance induced by both acute and chronic stress","volume":"16","author":"Wincewicz","year":"2015","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"key":"10.1016\/j.ejphar.2026.179400_bib223","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pbb.2016.06.010","article-title":"Angiotensin II type 1 receptor blockade by telmisartan prevents stress-induced impairment of memory via HPA axis deactivation and up-regulation of brain-derived neurotrophic factor gene expression","volume":"148","author":"Wincewicz","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2026.179400_bib224","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/biophysica6030046","article-title":"Telmisartan-induced alteration of voltage-gated na+ currents: integrated experimental and in silico approaches","volume":"6","author":"Wu","year":"2026","journal-title":"Biophysica"},{"key":"10.1016\/j.ejphar.2026.179400_bib226","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2015.06.005","article-title":"Effect of telmisartan on the therapeutic efficacy of pitavastatin in high-fat diet induced dyslipidemic Guinea pigs","volume":"762","author":"Xu","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib227","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2015.06.005","article-title":"Effect of telmisartan on the therapeutic efficacy of pitavastatin in high-fat diet induced dyslipidemic Guinea pigs","volume":"762","author":"Xu","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib225","doi-asserted-by":"crossref","first-page":"351","DOI":"10.33549\/physiolres.932433","article-title":"Administration of telmisartan reduced systolic blood pressure and oxidative stress probably through the activation of PI3K\/Akt\/eNOS pathway and NO release in spontaneously hypertensive rats","author":"Xu","year":"2013","journal-title":"Physiol. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib228","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00228-023-03602-4","article-title":"Physiologically based pharmacokinetic modeling of apixaban to predict exposure in populations with hepatic and renal impairment and elderly populations","volume":"80","author":"Xu","year":"2024","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib229","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.mehy.2004.09.015","article-title":"Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-\u03b3-inducing property","volume":"64","author":"Yamagishi","year":"2005","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ejphar.2026.179400_bib230","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/156652407781387073","article-title":"Potential utility of telmisartan, an angiotensin II type 1 receptor blocker with peroxisome proliferator-activated Receptor-\u03b3 (PPAR-\u03b3)-Modulating activity for the treatment of cardiometabolic disorders","volume":"7","author":"Yamagishi","year":"2007","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ejphar.2026.179400_bib231","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.149400","article-title":"The role of ACE inhibitors and ARBs in preserving cognitive function via hypertension management: a critical update","volume":"1850","author":"Yasmin","year":"2025","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib232","doi-asserted-by":"crossref","DOI":"10.1097\/01.hjh.0000379873.13405.81","article-title":"Telmisartan improves endothelial function in scleroderma patients with pulmonary hypertension: PP.33.335","volume":"28","author":"Yatsyshyn","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2026.179400_bib234","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.826811","article-title":"The role of peroxisome proliferator-activated receptor gamma and atherosclerosis: Post-translational modification and selective modulators","volume":"13","author":"Yin","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejphar.2026.179400_bib233","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/07435800.2013.828741","article-title":"Telmisartan increases lipoprotein lipase expression via peroxisome proliferator-activated receptor-alpha in HepG2 cells","volume":"39","author":"Yin","year":"2014","journal-title":"Endocr. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib235","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/hr.2013.141","article-title":"Comparative effects of telmisartan and valsartan as add-on agents for hypertensive patients with morning blood pressure insufficiently controlled by amlodipine monotherapy","volume":"37","author":"Yoshida","year":"2014","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib236","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081480","article-title":"Telmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease","volume":"8","author":"Yoshihara","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179400_bib237","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.metabol.2011.06.007","article-title":"Prophylactic treatment with telmisartan induces tissue-specific gene modulation favoring normal glucose homeostasis in cohen-rosenthal diabetic hypertensive rats","volume":"61","author":"Younis","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2026.179400_bib238","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejphar.2016.07.021","article-title":"Telmisartan-mediated metabolic profile conferred brain protection in diabetic hypertensive rats as evidenced by magnetic resonance imaging, behavioral studies and histology","volume":"789","author":"Younis","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179400_bib239","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1650319","article-title":"Association of pan-immune-inflammation value and atherogenic index of plasma with chronic coronary syndrome in non-alcoholic fatty liver disease patients","volume":"16","author":"Yu","year":"2025","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ejphar.2026.179400_bib240","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(08)61242-8","article-title":"Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial","volume":"372","author":"Yusuf","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2026.179400_bib241","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179400_bib242","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112606","article-title":"Antifibrotic effects of low dose SGLT2 Inhibition with empagliflozin in comparison to ang II receptor blockade with telmisartan in 5\/6 nephrectomised rats on high salt diet","volume":"146","author":"Zeng","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.179400_bib243","article-title":"Food and medicine homology components ameliorate metabolic diseases via dual pathways: blood absorption and nonabsorptive pathways","volume":"3","author":"Zhai","year":"2026","journal-title":"Food & Med. Homol."},{"key":"10.1016\/j.ejphar.2026.179400_bib244","article-title":"Effectiveness and safety of valsartan\/amlodipine in hypertensive patients with stroke","volume":"96","author":"Zhang","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.ejphar.2026.179400_bib245","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41598-024-84564-0","article-title":"Abnormal ac4C modification in metabolic dysfunction associated steatotic liver cells","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179400_bib248","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000500038","article-title":"Angiotensin II receptor type 1 antagonists modulate vascular smooth muscle cell proliferation and migration via AMPK\/mTOR","volume":"143","author":"Zhao","year":"2019","journal-title":"Cardiology"},{"key":"10.1016\/j.ejphar.2026.179400_bib246","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/291656","article-title":"Rosiglitazone restores endothelial dysfunction in a rat model of metabolic syndrome through PPAR\u03b3- and PPAR\u03b4-Dependent phosphorylation of Akt and eNOS","author":"Zhao","year":"2011","journal-title":"PPAR Res."},{"key":"10.1016\/j.ejphar.2026.179400_bib247","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jcjd.2013.03.024","article-title":"Angiotensin II receptor blocker telmisartan prevents new-onset diabetes in pre-diabetes OLETF rats on a high-fat diet: evidence of anti-diabetes action","volume":"37","author":"Zhao","year":"2013","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.ejphar.2026.179400_bib249","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2017.00231","article-title":"Temporal changes in cortical and hippocampal expression of genes important for brain glucose metabolism following controlled cortical impact injury in mice","volume":"8","author":"Zhou","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ejphar.2026.179400_bib251","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00281-022-00947-3","article-title":"The immunology of Parkinson's disease","volume":"44","author":"Zhu","year":"2022","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.ejphar.2026.179400_bib250","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/10641963.2018.1529781","article-title":"Angiotensin II type 1 receptor blockers prevent aortic arterial stiffness in elderly patients with hypertension","volume":"41","author":"Zhu","year":"2019","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.ejphar.2026.179400_bib252","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4149\/gpb_2022039","article-title":"Homocysteine promotes migration of adventitial fibroblasts via angiotensin II type 1 receptor activation to aggravate atherosclerosis","volume":"41","author":"Zhu","year":"2022","journal-title":"Gen. Physiol. Biophys."},{"key":"10.1016\/j.ejphar.2026.179400_bib253","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/jhh.2008.132","article-title":"Telmisartan versus angiotension-converting enzyme inhibitors in the treatment of hypertension: a meta-analysis of randomized controlled trials","volume":"23","author":"Zou","year":"2009","journal-title":"J. Hum. Hypertens."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926008824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926008824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:36:54Z","timestamp":1793079414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926008824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":253,"alternative-id":["S0014299926008824"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179400","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Telmisartan: distinct pharmacological features, partial PPAR-\u03b3 modulation, and pleiotropic therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179400","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179400"}}